The CMI (formerly Menaflex) is a resorbable collagen-based surgical mesh composed primarily of type I collagen.  It serves to reinforce damaged or weakened tissue and provides a resorbable scaffold for replacement by the patient's own tissue.

CMI is intended for use in patients with an irreparable meniscus tear or loss of meniscus tissue.  It is a proven safe and effective treatment for meniscus injuries.

CMI provides a template for the body to generate new meniscus-like tissue to replace the damaged meniscus tissue removed during a partial meniscectomy.  The CMI device is sutured into place to fill the meniscus defect following a partial meniscectomy and provides a matrix into which the body's own cells may begin to migrate.  New tissue is formed as these cells aggregate and multiply, and the CMI material is absorbed by the body.

This new tissue has the potential to restore function, reduce pain, and potentially delay the degenerative process that is initiated with the loss of meniscus tissue.

For details on indications, contraindications, precautions, and warnings for the CMI collagen meniscus implant and the specific instruments refer to the respective package inserts.